• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境中脂肪生成的翻译后调控。

Posttranslational control of lipogenesis in the tumor microenvironment.

机构信息

Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430072, China.

Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, Wuhan, 430071, China.

出版信息

J Hematol Oncol. 2022 Aug 29;15(1):120. doi: 10.1186/s13045-022-01340-1.

DOI:10.1186/s13045-022-01340-1
PMID:36038892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9422141/
Abstract

Metabolic reprogramming of cancer cells within the tumor microenvironment typically occurs in response to increased nutritional, translation and proliferative demands. Altered lipid metabolism is a marker of tumor progression that is frequently observed in aggressive tumors with poor prognosis. Underlying these abnormal metabolic behaviors are posttranslational modifications (PTMs) of lipid metabolism-related enzymes and other factors that can impact their activity and/or subcellular localization. This review focuses on the roles of these PTMs and specifically on how they permit the re-wiring of cancer lipid metabolism, particularly within the context of the tumor microenvironment.

摘要

肿瘤微环境中的癌细胞代谢重编程通常是对营养、翻译和增殖需求增加的反应。改变的脂质代谢是肿瘤进展的标志,在预后不良的侵袭性肿瘤中经常观察到。在这些异常代谢行为的背后,是脂质代谢相关酶和其他因素的翻译后修饰(PTMs),这些修饰可以影响它们的活性和/或亚细胞定位。这篇综述重点介绍了这些 PTMs 的作用,特别是它们如何允许重新连接癌症的脂质代谢,特别是在肿瘤微环境的背景下。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23ff/9422141/cc359343cb75/13045_2022_1340_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23ff/9422141/f981ca6af04c/13045_2022_1340_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23ff/9422141/fa937a54d56f/13045_2022_1340_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23ff/9422141/5ec1fdaeeb5c/13045_2022_1340_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23ff/9422141/708adc64e5e5/13045_2022_1340_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23ff/9422141/cc359343cb75/13045_2022_1340_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23ff/9422141/f981ca6af04c/13045_2022_1340_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23ff/9422141/fa937a54d56f/13045_2022_1340_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23ff/9422141/5ec1fdaeeb5c/13045_2022_1340_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23ff/9422141/708adc64e5e5/13045_2022_1340_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23ff/9422141/cc359343cb75/13045_2022_1340_Fig5_HTML.jpg

相似文献

1
Posttranslational control of lipogenesis in the tumor microenvironment.肿瘤微环境中脂肪生成的翻译后调控。
J Hematol Oncol. 2022 Aug 29;15(1):120. doi: 10.1186/s13045-022-01340-1.
2
Targeting dysregulated lipid metabolism in the tumor microenvironment.靶向肿瘤微环境中失调的脂质代谢。
Arch Pharm Res. 2023 Dec;46(11-12):855-881. doi: 10.1007/s12272-023-01473-y. Epub 2023 Dec 7.
3
Regulation of tumor metabolism by post translational modifications on metabolic enzymes.翻译:代谢酶的翻译后修饰对肿瘤代谢的调控。
Cancer Gene Ther. 2023 Apr;30(4):548-558. doi: 10.1038/s41417-022-00521-x. Epub 2022 Aug 23.
4
Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy.肿瘤微环境中脂质代谢的重编程:肿瘤免疫治疗的一种策略。
Lipids Health Dis. 2024 Feb 1;23(1):35. doi: 10.1186/s12944-024-02024-0.
5
LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer.长非编码 RNA 介导的癌症翻译后修饰和能量代谢重编程。
Cancer Commun (Lond). 2021 Feb;41(2):109-120. doi: 10.1002/cac2.12108. Epub 2020 Oct 29.
6
The posttranslational modifications of Hippo-YAP pathway in cancer.Hippo-YAP 通路在癌症中的翻译后修饰。
Biochim Biophys Acta Gen Subj. 2020 Jan;1864(1):129397. doi: 10.1016/j.bbagen.2019.07.006. Epub 2019 Jul 12.
7
Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics.肿瘤微环境中的脂质代谢重编程:从机制到治疗。
J Hematol Oncol. 2023 Sep 12;16(1):103. doi: 10.1186/s13045-023-01498-2.
8
New dawn for cancer cell death: Emerging role of lipid metabolism.癌症细胞死亡的新曙光:脂质代谢的新兴作用。
Mol Metab. 2022 Sep;63:101529. doi: 10.1016/j.molmet.2022.101529. Epub 2022 Jun 15.
9
Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer.脂质代谢重编程介导乳腺癌微环境成分的串扰、重塑和干预。
Int J Biol Sci. 2024 Mar 3;20(5):1884-1904. doi: 10.7150/ijbs.92125. eCollection 2024.
10
Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.多组学数据解析泛癌中脂质代谢失调及其对免疫微环境的影响。
BMC Bioinformatics. 2019 May 1;20(Suppl 7):195. doi: 10.1186/s12859-019-2734-4.

引用本文的文献

1
Lipid metabolites as biomarkers and therapeutic targets in oral squamous cell carcinoma.脂质代谢产物作为口腔鳞状细胞癌的生物标志物和治疗靶点
BMC Oral Health. 2025 Aug 31;25(1):1390. doi: 10.1186/s12903-025-06700-0.
2
Unlocking the lipid code: SREBPs as key drivers in gastrointestinal tumour metabolism.破解脂质密码:固醇调节元件结合蛋白作为胃肠道肿瘤代谢的关键驱动因素
Lipids Health Dis. 2025 May 24;24(1):190. doi: 10.1186/s12944-025-02612-8.
3
Unraveling the metabolic‒epigenetic nexus: a new frontier in cardiovascular disease treatment.

本文引用的文献

1
Targeting lipid metabolism in the treatment of ovarian cancer.靶向脂质代谢治疗卵巢癌。
Oncotarget. 2022 May 25;13:768-783. doi: 10.18632/oncotarget.28241. eCollection 2022.
2
Ammonia stimulates SCAP/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth.氨刺激 SCAP/Insig 解离和 SREBP-1 激活,促进脂肪生成和肿瘤生长。
Nat Metab. 2022 May;4(5):575-588. doi: 10.1038/s42255-022-00568-y. Epub 2022 May 9.
3
P53 deficiency affects cholesterol esterification to exacerbate hepatocarcinogenesis.
解析代谢-表观遗传关联:心血管疾病治疗的新前沿。
Cell Death Dis. 2025 Mar 18;16(1):183. doi: 10.1038/s41419-025-07525-z.
4
Drug Repurposing: A Conduit to Unravelling Metabolic Reprogramming for Cancer Treatment.药物再利用:揭示癌症治疗中代谢重编程的途径。
Mini Rev Med Chem. 2025;25(8):601-627. doi: 10.2174/0113895575339660250106093738.
5
Precise targeting of lipid metabolism in the era of immuno-oncology and the latest advances in nano-based drug delivery systems for cancer therapy.免疫肿瘤学时代脂质代谢的精准靶向以及用于癌症治疗的纳米药物递送系统的最新进展。
Acta Pharm Sin B. 2024 Nov;14(11):4717-4737. doi: 10.1016/j.apsb.2024.07.021. Epub 2024 Jul 27.
6
Roles of posttranslational modifications in lipid metabolism and cancer progression.翻译后修饰在脂质代谢和癌症进展中的作用。
Biomark Res. 2024 Nov 18;12(1):141. doi: 10.1186/s40364-024-00681-y.
7
Recent progress in gene therapy for familial hypercholesterolemia treatment.家族性高胆固醇血症治疗的基因疗法最新进展。
iScience. 2024 Aug 10;27(9):110641. doi: 10.1016/j.isci.2024.110641. eCollection 2024 Sep 20.
8
Lactylated Apolipoprotein C-II Induces Immunotherapy Resistance by Promoting Extracellular Lipolysis.乳酰化载脂蛋白 C-II 通过促进细胞外脂解诱导免疫治疗耐药性。
Adv Sci (Weinh). 2024 Oct;11(38):e2406333. doi: 10.1002/advs.202406333. Epub 2024 Jul 9.
9
TRIM21-Promoted FSP1 Plasma Membrane Translocation Confers Ferroptosis Resistance in Human Cancers.TRIM21 促进 FSP1 质膜易位赋予人类癌症的铁死亡抗性。
Adv Sci (Weinh). 2023 Oct;10(29):e2302318. doi: 10.1002/advs.202302318. Epub 2023 Aug 16.
10
DDIT4 Downregulation by siRNA Approach Increases the Activity of Proteins Regulating Fatty Acid Metabolism upon Aspirin Treatment in Human Breast Cancer Cells.通过小干扰RNA方法下调DDIT4可增强人乳腺癌细胞经阿司匹林处理后调节脂肪酸代谢的蛋白质的活性。
Curr Issues Mol Biol. 2023 May 28;45(6):4665-4674. doi: 10.3390/cimb45060296.
p53 缺失影响胆固醇酯化作用,从而加重肝癌的发生。
Hepatology. 2023 May 1;77(5):1499-1511. doi: 10.1002/hep.32518. Epub 2023 Apr 17.
4
Acetyl-CoA synthetases ACSS1 and ACSS2 are 4-hydroxytamoxifen responsive factors that promote survival in tamoxifen treated and estrogen deprived cells.乙酰辅酶A合成酶ACSS1和ACSS2是4-羟基他莫昔芬反应因子,可促进他莫昔芬处理的细胞和雌激素剥夺细胞的存活。
Transl Oncol. 2022 May;19:101386. doi: 10.1016/j.tranon.2022.101386. Epub 2022 Mar 6.
5
Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer.癌症中免疫检查点的代谢调节和新的治疗策略。
Semin Cancer Biol. 2022 Nov;86(Pt 3):542-565. doi: 10.1016/j.semcancer.2022.02.010. Epub 2022 Feb 10.
6
USP19 exacerbates lipogenesis and colorectal carcinogenesis by stabilizing ME1.USP19 通过稳定 ME1 加剧脂肪生成和结直肠肿瘤发生。
Cell Rep. 2021 Dec 28;37(13):110174. doi: 10.1016/j.celrep.2021.110174.
7
Ceramide-mediated gut dysbiosis enhances cholesterol esterification and promotes colorectal tumorigenesis in mice.鞘氨醇介导的肠道菌群失调增强胆固醇酯化作用并促进小鼠结直肠肿瘤发生。
JCI Insight. 2022 Feb 8;7(3):e150607. doi: 10.1172/jci.insight.150607.
8
Too complex to fail? Targeting fatty acid metabolism for cancer therapy.过于复杂而不会失败?针对脂肪酸代谢的癌症治疗。
Prog Lipid Res. 2022 Jan;85:101143. doi: 10.1016/j.plipres.2021.101143. Epub 2021 Nov 29.
9
Contradictory roles of lipid metabolism in immune response within the tumor microenvironment.脂质代谢在肿瘤微环境中的免疫反应中的矛盾作用。
J Hematol Oncol. 2021 Nov 6;14(1):187. doi: 10.1186/s13045-021-01200-4.
10
Nanoparticle-Mediated Lipid Metabolic Reprogramming of T Cells in Tumor Microenvironments for Immunometabolic Therapy.用于免疫代谢治疗的肿瘤微环境中纳米颗粒介导的T细胞脂质代谢重编程
Nanomicro Lett. 2021 Jan 4;13(1):31. doi: 10.1007/s40820-020-00555-6.